Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

EQS-News: CGM receives C5 attestation according to BSI Criteria


EQS-News: CompuGroup Medical SE Co. KGaA / Key word(s): Miscellaneous
CGM receives C5 attestation according to BSI Criteria

01.07.2024 / 11:31 CET/CEST
The issuer is solely responsible for the content of this announcement.


CGM receives C5 attestation according to BSI Criteria  

Koblenz - CompuGroup Medical (CGM) has received C5 attestation (Type 1) for cloud services in Germany in accordance with the criteria of the German Federal Office for Information Security (BSI). Cloud products of CGM have been attested compliance with C5 criteria retroactively as of May 31, 2024 by an independent auditing company.

The German Digital Act (DigiG) prescribes C5 (Type 1) as the security standard for cloud services in the German healthcare and social services sector from July 1, 2024. C5 (Cloud Computing Compliance Criteria Catalogue) was developed by the BSI and specifies requirements for secure cloud computing. It contains more than 120 security criteria, including the areas of information security organization, physical security, regular operations, portability and interoperability. These criteria are regularly reviewed by independent auditors.

CompuGroup Medical offers its customers high security standards in the processing of healthcare data. The C5-attested cloud applications in Germany are another milestone on this path,” says Michael Rauch, CEO of CompuGroup Medical. 

The C5 attestation provides customers with important guidance when selecting a cloud provider and supports healthcare professionals in meeting the strict requirements for information security. Based on a standardized examination and report, it provides transparency on the information security status of a cloud service.

Further information on the C5 attestation for CGM can be found here: www.cgm.com/c5-testat

 



01.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1936937

 
End of News EQS News Service

1936937  01.07.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1936937&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533

CompuGroup Medical SE & Co. KGaA Aktie

23,52 €
-2,34 %
Die CompuGroup Medical SE & Co. KGaA Aktie erleidet heute einen spürbaren Rückgang von -2,34 %.

Like: 0
Teilen
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Rechtlicher Hinweis

Kommentare